Page last updated: 2024-10-23

aspirin and Eosinophilic Esophagitis

aspirin has been researched along with Eosinophilic Esophagitis in 4 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Eosinophilic Esophagitis: Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.

Research Excerpts

ExcerptRelevanceReference
"Our data suggests that lymphocytic esophagitis is more likely to be found in older female patients and is significantly associated with achalasia, statin, and aspirin use."4.02Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes. ( Bi, Y; Brahmbhatt, B; DeVault, KR; Ghoz, H; Krishna, M; Lacy, BE; Malviya, BJ; Palmer, WC; Zaver, HB, 2021)
"Endoscopic features of eosinophilic esophagitis (EoE) are variable with at least 2 phenotypes."1.43Impact of Diagnostic Delay and Other Risk Factors on Eosinophilic Esophagitis Phenotype and Esophageal Diameter. ( Kumar, A; Lipka, S; Richter, JE, 2016)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Zaver, HB1
Ghoz, H1
Malviya, BJ1
Brahmbhatt, B1
Palmer, WC1
Lacy, BE1
DeVault, KR1
Krishna, M1
Bi, Y1
Eid, RC1
Palumbo, ML1
Laidlaw, TM1
Buchheit, KM1
Cahill, KN1
Lipka, S1
Kumar, A1
Richter, JE1
Pelletier, T1
Tamayev, R1
Iammatteo, M1
Nautsch, D1
Hudes, G1
Lukin, D1
Jerschow, E1

Other Studies

4 other studies available for aspirin and Eosinophilic Esophagitis

ArticleYear
Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes.
    Digestive diseases and sciences, 2021, Volume: 66, Issue:11

    Topics: Aged; Aspirin; Biopsy; Eosinophilic Esophagitis; Esophageal Achalasia; Esophagitis; Euterpe; Female;

2021
A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease.
    The journal of allergy and clinical immunology. In practice, 2019, Volume: 7, Issue:4

    Topics: Aspirin; Asthma, Aspirin-Induced; Cyclooxygenase Inhibitors; Desensitization, Immunologic; Eosinophi

2019
Impact of Diagnostic Delay and Other Risk Factors on Eosinophilic Esophagitis Phenotype and Esophageal Diameter.
    Journal of clinical gastroenterology, 2016, Volume: 50, Issue:2

    Topics: Adult; Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chi-Square Distribution;

2016
Eosinophilic esophagitis as possible complication of aspirin treatment in patient with aspirin-exacerbated respiratory disease.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2017, Volume: 118, Issue:1

    Topics: Adult; Aspirin; Asthma, Aspirin-Induced; Eosinophilic Esophagitis; Female; Humans; Nasal Polyps

2017